
Meslataj DR 800mg Tablet
Marketer
Taj Pharma India Ltd
Salt Composition
Mesalazine (800mg)
Overview Meslataj DR 800mg Tablet
Ulcerative colitis and Crohn's ileocolitis can be managed with the anti-inflammatory medication, Meslataj DR 800mg Tablet. This tablet alleviates symptoms like abdominal pain, rectal bleeding, and diarrhea by targeting bowel inflammation. Always take it with food, adhering strictly to your physician's prescribed dosage and duration. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Common side effects include nausea, vomiting, abdominal discomfort, headache, itching, gas, and loose stools. Report persistent, worsening, or bothersome side effects to your doctor; management strategies may be available. Seek immediate medical attention for severe allergic reactions indicated by facial, tongue, or throat swelling; unusual bleeding or bruising; rash; fever; sore throat; or extreme fatigue. Prior to commencing treatment, inform your doctor of any existing liver or kidney conditions, gastrointestinal obstructions, and your current medications, as interactions are possible. Age and pregnancy/breastfeeding status should also be disclosed, impacting suitability.
Uses of Meslataj DR 800mg Tablet
Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease.
Major Benefits of Meslataj DR 800mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 800mg Meslataj DR tablet whole; avoid chewing, crushing, or fracturing it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Meslataj DR 800mg Tablet:
- Stomach pain/epigastric pain
- Flatulence
- Headache
- Vomiting
- Diarrhea
- Nausea
- Abdominal pain
- Rash
How to use Meslataj DR 800mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meslataj DR 800mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Meslataj DR 800mg Tablet works:
Meslataj DR 800mg tablets contain an aminosalicylate that acts by inhibiting the synthesis of inflammatory prostaglandins in the intestinal tract. This mechanism diminishes ulceration, bleeding, and abdominal pain, while also mitigating the recurrence of disease symptoms.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining alcohol and Meslataj DR 800mg Tablets. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Using Meslataj DR 800mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Meslataj DR 800mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Mothers using Meslataj DR 800mg Tablet should closely observe their babies for signs of diarrhea.
DrivingSAFE
Driving ability is typically unaffected by Meslataj DR 800mg Tablet.
KidneyCAUTION
Exercise caution when administering Meslataj DR 800mg Tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Meslataj DR 800mg Tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Meslataj DR 800mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Meslataj DR 800mg Tablet :
Should you forget a Meslataj DR 800mg Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Meslataj DR 800mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Salicylic Acid Derivative |
| Developing Habits | No. |
| Treatment Category | Digestive |
| Behavioral Class | Mesalamine (5-ASA) |
